Navigation Links
Florastor(R) Receives ConsumerLab.com Certification
Date:3/11/2008

he enteric protection of the product, meaning the microorganisms' ability to survive as they make their way through stomach acid and into the small intestine where bacteria would flourish.

"Florastor is the most widely used probiotic in the world and is the product of extensive and ongoing research," says Berry. "It is very important to us that its claims have been validated by a reputable third party so that U.S. consumers can have confidence in the product."

Florastor, which utilizes a freeze-dried form of a beneficial yeast called Saccharomyces boulardii (S. boulardii), was voluntarily submitted for ConsumerLab.com testing and passed the organization's review criteria by meeting its listed number of 10 billion probiotic organisms in a maximum suggested daily serving, as well as being free of microbial contamination and exhibiting sufficient enteric protection.

Florastor is supported by numerous clinical studies and is the only probiotic mentioned by the World Health Organization (WHO) for use in managing recurrent disease associated with the Clostridium difficile (C. diff) infection(1). It is clinically proven to be effective in helping to manage intestinal issues ranging from acute diarrhea to chronic inflammatory conditions (such as Crohn's disease or ulcerative colitis). Florastor has also been clinically proven to be particularly effective in combating antibiotic-associated diarrhea, since, unlike bacteria-based probiotics, the beneficial yeast in Florastor cannot be killed by the antibiotic treatment itself.

Probiotics are defined by the Food and Agriculture Organization (FAO) of the United Nations, as "live microorganisms administered in adequate amounts, which confer a beneficial health effect on the host." Florastor has shown in more than 50 years of extensive international use to be safe and effective, with an estimated 1.7 billion daily doses sold to date.

Florastor is available in most retail chain pharmacies, and at
'/>"/>

SOURCE Florastor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial
2. Vermillion Receives Award From the Society of Gynecologic Oncologists
3. Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM)
4. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
5. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
6. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
7. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
8. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
10. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
11. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 21, 2014   BioNano Genomics , the ... research centers to purchase an Irys™ System . ... Cancer Institute (NCI), NIH Intramural Sequencing Center (NISC) and ... obtaining a comprehensive view of a genome was ... does not deliver the scalability or reliability to ...
(Date:10/22/2014)... Oct. 21, 2014 Abaxis, Inc. (NasdaqGS: ... blood analysis systems, today reported financial results for the ... Second quarter overview: , Revenues of $53.9 million, ... Diluted EPS of $0.24, up 33% over last year,s ... revenues from Abaxis Veterinary Reference Laboratories (AVRL) of $3.5 ...
(Date:10/22/2014)...   Surefire Medical , Inc., the developer of ... targeted delivery of embolization agents in minimally invasive direct-to-tumor ... John R. Daniels , MD of the University of ... Steven C. Katz , MD of the Roger ... Board (SAB).    "The role of the ...
Breaking Medicine Technology:BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 2Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 3Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 4Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 5Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 6Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 7Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 8Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 9Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 10Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 11Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 12Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 13Abaxis Reports Record Revenues for the Second Quarter of Fiscal 2015 14Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2
... , , FRANKLIN LAKES, N.J., Jan. 11 ... announced today that it will conduct a live webcast of its ... 2010 at 10:00 a.m. (ET). BD will issue a press ... of the conference call, along with related slides, will be accessible ...
... Calif., Jan. 11 Finesse Solutions, LLC, a manufacturer ... applications, announced the production release of its single-use sensor ... and process temperature, and TruTorr headspace pressure sensors. ... ease of use. It is available on the Thermo ...
Cached Medicine Technology:BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call 2Single-Use Sensor Product Family Enters High Volume Production 2
(Date:10/22/2014)... On October 22, CBS will air an episode ... fictional and real. The Charles E Holman Morgellons ... advocacy and philanthropy in the battle against Morgellons Disease, ... impart truth and clarity about this misunderstood and routinely ... about Morgellons Disease (MD) and most people ...
(Date:10/22/2014)... By Amy Norton ... -- Headlines remain riveted on the three Ebola cases in ... much bigger health threat to Americans. President Barack Obama ... response to the virus, which has infected two Dallas nurses ... this month at Texas Health Presbyterian Hospital. But the ...
(Date:10/22/2014)... Angeles, California (PRWEB) October 22, 2014 Hay ... 2.0: Move Beyond Addiction and Upgrade Your Life (Paperback; $10.82) ... field of Yoga & Recovery. This book is meant ... thrive in a life of recovery. , Recovery 2.0 ... the 12 Steps; Recovery 2.0 is a guide for what ...
(Date:10/22/2014)... 22, 2014 Healthcare professionals who ... continuing education at home or on-the-go via laptops, ... 20 brand new, premium Seminar-on-Demand CE courses. The ... over 2,000 hours of CE course ... educational experience. With such a diverse library, there’s ...
(Date:10/22/2014)... (PRWEB) October 22, 2014 Richard Carlson, ... an industry leader with over 25 years experience. ... leader in the areas related to EDI, B2B Commerce, ... is an Editorial Advisory Board member for Pharmaceutical Commerce ... Blue Fin Group is a management and technology ...
Breaking Medicine News(10 mins):Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 2Health News:Hay House Announces The Official Release of Recovery 2.0: Move Beyond Addiction and Upgrade Your Life 3Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2
... estimated 15,000 - 20,000,members, ATLANTA, Dec. 4 ... week, to accommodate its growing membership in,DeKalb County ... ceremony for the new Stonecrest Medical Center was ... Ramsey, Georgia State,Representative Stan Watson, DeKalb County Commissioner ...
... The National,Organization of Life & Health Insurance Guaranty ... associations that are playing,a central role in the ... Company of New York (ELNY) matter., NOLHGA ... the ELNY situation: "NOLHGA and all of our ...
... antibiotics and nasal steroids don,t lessen symptoms , , TUESDAY, ... work no better than a placebo in combating sinus ... probably not as effective as have been previously believed, ... said study author Dr. Ian Williamson, a senior lecturer ...
... BMIs experience a significant survival benefit from liver ... transplant compared to patients with normal BMI. Therefore, ... listed for transplantation, say the authors of a ... a journal by John Wiley & Sons. The ...
... and heart,s electrical system , , TUESDAY, Dec. 4 (HealthDay ... spotted patients at highest risk of cardiac arrest or ... researchers report. , "This is important because past studies, ... people at risk," said study lead author Dr. Derek ...
... M.D., Chair of,Neurosurgery at Yale University School of ... American Epilepsy Society (AES), during the,organization,s 61st annual ... physicians and scientists who study and treat epilepsy., ... surgical treatment of,neurological diseases causing epilepsy. He developed ...
Cached Medicine News:Health News:Kaiser Permanente Opens 15th Medical Facility in Georgia 2Health News:Statement on Executive Life of New York Matter 2Health News:Sinusitis Treatments Found Ineffective 2Health News:Sinusitis Treatments Found Ineffective 3Health News:Liver transplant offers survival benefits for patients of all sizes 2Health News:Liver transplant offers survival benefits for patients of all sizes 3Health News:2-in-1 Test Signals Risk After Heart Attack 2Health News:2-in-1 Test Signals Risk After Heart Attack 3
... 20-dione) is a C21 steroid hormone containing ... between C-4 and C-5 (?4).,This steroid hormone ... conjunction with estrogens, regulates,the accessory organs during ... important in preparing the,endometrium for the implantation ...
... The test kit is an enzyme ... format with a liquid phase,incubation, designed ... in serum. The microplate is coated,with ... added to anti-rabbit antibody-coated wells, along ...
Myoglobin RIA Lipid / Protein Quantification, Cardiovascular 024-IDC-11 Muscle Disease...
ACTH EIA Hypertension / Cardiac Evaluation, Cardiovascular 021-SDX018...
Medicine Products: